Profiel
Charmaine Lykins served as Vice President of Marketing at Lundbeck Pharmaceuticals Ltd.
from 2013 to 2018 and at ACADIA Pharmaceuticals, Inc. from 2018 to 2019.
She will serve as Chief Commercial Officer at Karuna Therapeutics, Inc. from 2021 to 2023.
Lykins earned an undergraduate degree from Ball State University in 1993 and an MBA from Darla Moore School of Business in 2000.
Eerdere bekende functies van Charmaine Lykins
| Bedrijven | Functie | Einde |
|---|---|---|
| KARA THER | Corporate Officer/Principal | 05-01-2023 |
| Lundbeck Pharmaceuticals Ltd. | Sales & Marketing | 01-02-2018 |
| ACADIA PHARMACEUTICALS INC. | Sales & Marketing | - |
Opleiding van Charmaine Lykins
| Ball State University (Indiana) | Undergraduate Degree |
| Darla Moore School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Lundbeck Pharmaceuticals Ltd. | |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
